Indicated for: angina pectoris
Route of administration: oral
Substance: pentaerythrityl tetranitrate (antihypertensive)
ATC: C01DA05 (Cardiovascular system | Vasodilators used in cardiac diseases | Organic nitrates)
Pentaerythritol tetranitrate (PETN) is a medication primarily used for the treatment and prevention of angina pectoris, a condition caused by reduced blood flow to the heart. It belongs to the class of organic nitrates and works by relaxing blood vessels, improving blood flow, and reducing the workload on the heart.
This medication is used to prevent episodes of angina pectoris but is not indicated for the treatment of acute angina attacks. PETN is also sometimes used in the management of chronic heart failure, as it helps reduce pressure on the heart and improve cardiac function.
Although effective, the use of pentaerythritol tetranitrate should be approached with caution. It may cause side effects such as headaches, dizziness, low blood pressure (hypotension), or nausea. Prolonged use can lead to the development of tolerance, meaning the medication's effectiveness may decrease over time.
This medication should be used as directed by a doctor, and patients should adhere to the prescribed dosage. It is important to avoid alcohol consumption during treatment, as it may enhance adverse effects. If unusual or severe symptoms occur, immediate medical attention is necessary.